Stay updated on ADVOCATE: Avacopan Clinical Trial
Sign up to get notified when there's something new on the ADVOCATE: Avacopan Clinical Trial page.

Latest updates to the ADVOCATE: Avacopan Clinical Trial page
- Check3 days agoChange DetectedThe webpage has updated its last update date to March 2025 and included information about a study acquired by Amgen, indicating a change in sponsorship.SummaryDifference0.7%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check39 days agoChange DetectedThe page has replaced the mention of ChemoCentryx with Amgen, indicating a significant change in the focus or representation of companies on the page.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
- Check53 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check67 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
Stay in the know with updates to ADVOCATE: Avacopan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVOCATE: Avacopan Clinical Trial page.